Immunizing Ldlr−/− mice with preparations of S. pneumoniae significantly elevated NAb IgM titers and reduced plaque development, thus demonstrating the presence of molecular mimicry between S. pneumoniae and oxLDL in addition to a potential mechanism by which NAbs generally restrain ASCVD progression. The gene discussed is LDLR; the disease is atherosclerosis.